Vnitr Lek 2018, 64(4):427-431 | DOI: 10.36290/vnl.2018.060

Acquired hemophilia A: case report

Štefan Sotak1,*, Miriam Mitníková2
1 I. interná klinika LF UPJŠ a UN L. Pasteura Košice, Slovenská republika
2 Oddelenie labortórnej medicíny LF UPJŠ a UN L. Pasteura Košice, Slovenská republika

Case report of a 74-year-old male with acquired hemophilia A, whose etiology was not found, confirmed by hemocoagulation examinations, with clinical manifestation of protracted macroscopic hematuria, spontaneous skin and intramuscular bleedings. Treatment comprised conservative therapy administration of hemostyptics, red blood cells transfusions application of recombinant human factor VII (rFVII) and immunosuppression. Finally, patient died due to nosocomial infection caused by multidrug-resistant pulmonary pathogen.

Keywords: acquired hemophilia A; bleeding

Received: October 20, 2017; Accepted: December 14, 2017; Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sotak Š, Mitníková M. Acquired hemophilia A: case report. Vnitr Lek. 2018;64(4):427-431. doi: 10.36290/vnl.2018.060.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Theodossiades G, Kontopoulou-Griva I. Acquired haemophilia A. Haema 2002; 5: 282-290.
    2. Franchini M, Castaman G, Coppola A et al. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus 2015; 13(3): 498-513. Dostupné z DOI: <http://dx.doi.org/10.2450/2015.0141-15>. Go to PubMed...
    3. Bainton R, Makris M. The diagnosis and management of acquired hemophilia. CME Bulletin Haematology 2000; 3(1): 3-5.
    4. Baudo F, De Cataldo F. Acquired hemophilia: a critical bleeding syndrome. Haematologica 2004; 89(1): 96-100. Go to PubMed...
    5. Collins P, Macartney N, Davies R et al. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J of Haemathol 2004; 124(1): 86-90. Go to original source... Go to PubMed...
    6. Collins PW, Percy CL. Advances in the understanding of acquired haemophilia A: implications for clinical practice. Br J Haematol 2010; 148(2): 183-194. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2141.2009.07915.x>. Go to original source... Go to PubMed...
    7. Bona D, Schiavoni M, Castaman G et al. Acquired hemophilia: experience of two Italian centres with 27 new cases. Haemophilia 1997; 3(3): 183-188. Dostupné z DOI: <http://dx.doi.org/10.1046/j.1365-2516.1997.00102.x>. Go to original source... Go to PubMed...
    8. Collins PW, Hirsch S, Baglin TP et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctor' Organisation. Blood 2007; 109(5): 1870-1877. Dostupné z DOI: <http://dx.doi.org/10.1182/blood-2006-06-029850>. Go to original source... Go to PubMed...
    9. Knöbl P, Marco P, Baudo F et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10(4): 622-631. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1538-7836.2012.04654.x>. Go to original source... Go to PubMed...
    10. Borg JY, Guillet B, Le Cam-Duchez V et al. Outcome of acquired haemophilia in France: the prospective SACHA. Haemophilia 2013; 19(4): 564-570. Dostupné z DOI: <http://dx.doi.org/10.1111/hae.12138>. Go to original source... Go to PubMed...
    11. Tiede A, Klamroth R, Scharf RE et al. Prognostic factors for remission of and survival in acquired hemophilia A: results from the GTH-AH 01/2010 study. Blood 2015; 125(7): 1091-1097. Dostupné z DOI: <http://dx.doi.org/10.1182/blood-2014-07-587089>. Go to original source... Go to PubMed...
    12. Mansouritorghabeh H. Clinical and Laboratory Approaches to Hemophilia A. Iran J Med Sci 2015; 40(3): 194-205.
    13. Buliková A, Smejkal P, Zavřelová J et al. Získané inhibitory krevního srážení. Interní Med 2008; 10(7-8): 336-339.
    14. Sániová B. Použitie rekombinantného faktora VIIa počas masívnych tehotenských krvácaní. Vask Med 2016; 8(3): 107-109.
    15. Hay CR, Baglin TP, Collins PW et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). Br J Haemathol 2000; 111(1): 78-90. Go to original source... Go to PubMed...
    16. Collins PW. Management of acquired haemophilia A - more questions than answers. Blood Coagul Fibrinolysis 2003; 14(Suppl 1): S23-S27. Go to original source... Go to PubMed...
    17. Tengborn L, Ingerslev J, Mäkipernaa A et al. Acquired haemophilia. Nordic guidelines for diagnosis and treatment, version 2006. Dostupné z DOI: <http://www.hematology.fi/sites/default/files/uploads/nordic_hemophilia_guidelines_final_20150623.pdf>.
    18. Kubisz P, Staško J, Hollý P. Získaná hemofília A. Inter Med 2005; 5(12): 702-706.
    19. Karimi M, Abdolkarimi B, Majid N et al. Acquired Hemophilia: A Report of 4 Cases. Ann Hematol Oncol 2016; 3(1): 1074.
    20. Kershaw G, Favaloro EJ. Laboratory identification of factor inhibitors: an update. Pathology 2012; 44(4): 293-302. Dostupné z DOI: <http://dx.doi.org/10.1097/PAT.0b013e328353254d>. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.